BELLSHILL, SCOTLAND — LINK (www.linktech.co.uk), the specialist oligonucleotide reagent developer and manufacturer, has announced the appointment of Dr David Ricketts as its new Chief Executive Officer, taking over the position from current CEO, Dr John Bremner, on 20 October 2014. Of his appointment, Dr Ricketts said: “I’m delighted and very excited to join LINK as […]
Cambridge, UK and St. Louis, MO, USA –- Horizon Discovery Group plc (LSE: HZD) (“Horizon” or the “Company”), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has agreed to acquire Sage Labs Inc. (Sage) for up to $16M […]
BioCision LLC, the leading developer of advanced thermal technologies for biospecimen handling and standardization today announced the company has moved its global headquarters to San Rafael, California. The newly renovated office located at 101 Glacier Point Road Suite E reflects the company’s accelerated growth due to rapid adoption of its thermal regulation products by its […]
SomaLogic, Inc. and NEC Corporation (TYO: 6701) announced today an agreement that gives NEC exclusive marketing rights in Japan for SomaLogic’s SOMAscan™ assay, which is built on SomaLogic’s proprietarySOMAmer® technology. Under the agreement, NEC will offer access to the SOMAscan assay to biopharmaceutical companies, food companies, and academic research centers for their research in Japan. […]
Madison, WI — The National Cancer Institutes has awarded a $1.75M Small Business Innovative Research (SBIR) contract to BellBrook Labs for a collaborative effort with researchers at the University of Wisconsin-Madison to develop more realistic models for breast and ovarian cancer. The research will use imaging and microfabrication technology developed by the UW team to […]
STEMCELL Technologies has received $949,500 in repayable assistance from the Western Innovation (WINN) Initiative for an exciting project to develop tools and assays for three-dimensional (3D) cell culture. Led by Dr. Steven Woodside, Director of Particle Chemistry and Engineering, and Dr. Eric Jervis, Principal Scientist, the project builds on STEMCELL Technologies’ extensive experience in developing […]
Cambridge, UK — Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announces that its business unit Horizon Diagnostics has signed a Master Services Agreement with a major global diagnostic development company and a US biopharmaceutical company to support the […]
San Diego, CA — FBXL11 (KDM2A) and FBXL10 (KDM2B) are F-box and Jumonji domain-containing enzymes that specifically demethylate mono- and di-methylated lysine 36 of histone H3 (H3K36) in a Fe(II) and ?-ketoglutarate (?KG)-dependent manner. Unlike most methyllysine histone modifications, methylation of H3K36 is associated with active chromatin and gene transcription. FBXL10 was also reported to […]
North Brunswick, NJ, USA — Hurel Corporation (“Hurel”), a world-leading provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, today announced that Johnston Associates, Inc. of Princeton, New Jersey (“JAI”) has become a participating investor in the Company’s Series A-3 Preferred Stock financing. Hurel’s lead […]
Lakewood, N.J. — Animal Origin Free (AOF) STEMxyme® collagenase/neutral protease (Dispase®) Blends 1 and 2, produced by Worthington Biochemical Corporation, are now available for primary and stem cell isolation, regenerative medicine, biopharmaceutical and cell bioprocessing applications. These new, specialized combinations of AOF Clostridium histolyticum collagenase and AOF Bacillus polymyxa neutral protease (Dispase®) offer a minimum […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
